Imaging features of uterine and ovarian fibromatosis in Nevoid Basal Cell Carcinoma Syndrome

Gorlin-Goltz Syndrome also known as Nevoid Basal Cell Carcinoma Syndrome is an autosomal dominant multisystem disorder. It is characterized by basal cell carcinomas, odontogenic keratocysts, skeletal abnormalities and in a minority of female patients bilateral calcified ovarian fibromas. It is challenging to radiologically assess ovarian fibromas as they have similar imaging patterns to some malignant ovarian lesions. However, it is vitally important to differentiate between benign and malignant lesions to determine patients' suitability for fertility-sparing surgery. This report describes a case of a 25 year-old patient with Gorlin-Goltz Syndrome and bilateral ovarian fibromas

KPC-3 Klebsiella pneumoniae ST258 clone infection in postoperative abdominal surgery patients in an intensive care setting: analysis of a case series of 30 patients

Objective: We studied the clinical course, Intensive Care Unit (ICU) and hospital outcomes of 30 postoperative abdominal surgery patients who showed severe infections caused by Klebsiella pneumoniae Sequence Type 258 producing K. pneumoniae carbapenemase 3 (KPC-Kp). Methods: Patients with at least two positive blood cultures for KPC-Kp after admission to the ICU were recruited for a 12-month period and treated with a combination regimen of colistin plus tigecycline. They were started on a high-dose (initial dose of 200 mg then 100 q12) of tigecycline combined with colistin, taking into account intra-abdominal abscess severity and MCIs for tigecycline. Results: The average age of the patients was 56.6 ± 15 (male = 16, female = 14), average APACHE score on admission was 22.72. Twenty out of 30 patients (66%) came from the surgical emergency unit. Patients showed KPC-Kp postoperative infection as follows: intra-abdominal abscess in 15 patients (50%), anastomotic leakage in 8 (24%), surgical site infection (SSI) in 4 (12%) and peritonitis in 3 (10%). Overall crude mortality rate in the ICU due to infection was 40% (12 out of 30 patients). Twelve out of 30 patients (40%) were started on a combination treatment of high-dose tigecycline and intravenous colistin; five of them showed tigecycline MICs of 0.8 - 1. Mortality was significantly associated with a greater number of surgical procedures, previous ICU admission (<0.0005), APACHE II ( p=0.018)and SOFA score (p<0.0005) and VAP (0.013). Treatment with high doses of tigecycline obtained a favourable outcome in patients with intraabdominal abscess. Discussion: Critically-ill surgical patients with KPC-Kp infections have to be treated in a timely manner, taking into account the severity of post-operative complications such as intra-abdominal abscess and anastomotic leakage. In these cases, early suspicion and detection are essential to reducing infection-related morbidity and mortality. Finally, studies evaluating antibiotic combination therapy and well-controlled clinical trials are needed to define the optimal treatment of infections caused by KPC-Kp and, more generally, carbapenem-resistant bacteria

Levonorgestrel-releasing intra-uterine systems as female contraceptives

The availability and use of long-acting reversible contraceptives (LARCs), such as levonorgestrel intrauterine systems (LNG-IUSs), have increased in recent times. Areas covered: The authors provide a narrative review of the LNG-IUSs currently available worldwide as female contraceptives (LNG-IUS 13.5, 19.5 and 52&nbsp;mg). Specific features of the devices and their parameters of efficacy and tolerability were considered as outcomes. Expert opinion: The one-handed 3.8-mm-diameter inserter of LNG-IUS 13.5&nbsp;mg and 19.5&nbsp;mg may be particularly suitable in nulliparous women. While LNG-IUSs 13.5, 19.5&nbsp;mg and LNG 52&nbsp;mg should be used by women simply looking for an effective contraceptive method for up to 3, 4 or 5&nbsp;years, LNG-IUS 52&nbsp;mg has also been approved for the treatment of heavy menstrual bleeding and endometrial protection during hormone replacement therapy. LNG-IUS 52&nbsp;mg is ideal for women who are experiencing a certain hyperestrogenic hormonal environment, with heavy menstrual bleeding due to hormonal imbalances, adenomyosis or fibroids, in the case of symptomatic endometriosis or for endometrial protection during hormone estrogenic replacement therapy in non-hysterectomized women